The synthetic hallucinogen, 2C-B, that has been offered in Latin American and Caribbean areas as “cocaina rosada” could cause a range of unwanted effects.Medication marketed as “pink copyright” may incorporate any range of drugs and additives capable of leading to delicate to critical consequences on health.Among the principal risks of pink